WO2010105842A3 - Zubereitung zur äusserlichen anwendung - Google Patents

Zubereitung zur äusserlichen anwendung Download PDF

Info

Publication number
WO2010105842A3
WO2010105842A3 PCT/EP2010/001742 EP2010001742W WO2010105842A3 WO 2010105842 A3 WO2010105842 A3 WO 2010105842A3 EP 2010001742 W EP2010001742 W EP 2010001742W WO 2010105842 A3 WO2010105842 A3 WO 2010105842A3
Authority
WO
WIPO (PCT)
Prior art keywords
water
cosmetic
therapeutic
oil
external application
Prior art date
Application number
PCT/EP2010/001742
Other languages
English (en)
French (fr)
Other versions
WO2010105842A9 (de
WO2010105842A2 (de
Inventor
Dirk Schumann
Original Assignee
Bubbles And Beyond Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bubbles And Beyond Gmbh filed Critical Bubbles And Beyond Gmbh
Priority to EP10712702A priority Critical patent/EP2408429A2/de
Priority to KR1020147014460A priority patent/KR20150000463A/ko
Priority to CN2010800128128A priority patent/CN102387787A/zh
Priority to JP2012500151A priority patent/JP2012520837A/ja
Priority to US13/257,100 priority patent/US20120064011A1/en
Publication of WO2010105842A2 publication Critical patent/WO2010105842A2/de
Publication of WO2010105842A3 publication Critical patent/WO2010105842A3/de
Publication of WO2010105842A9 publication Critical patent/WO2010105842A9/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Die vorliegende Erfindung betrifft Zubereitungen zur äußerlichen Anwendung auf die Haut von Tier und Mensch umfassend a) eine Zusammensetzung in Form eines fluides Nanophasensystems umfassend die Komponenten a1) mindestens eine wasserunlösliche Substanz mit einer Wasserlöslichkeit von weniger als 4 Gramm pro Liter, a2) mindestens eine amphiphile Substanz (NP-MCA), die keine Tensidstruktur aufweist, alleine nicht strukturbildend ist, deren Löslichkeit in Wasser bzw. Öl zwischen 4 g und 1000 g pro Liter beträgt und die sich nicht bevorzugt an der Öl-Wasser-Grenzfläche anreichert, a3) mindestens ein anionisches, kationisches, amphoteres und/oder nichtionisches Tensid, a4) mindestens ein polares protisches Lösungsmittel, insbesondere mit Hydroxyfunktionalität, a5) gegebenenfalls ein oder mehrere Hilfsstoffe, wobei sich die Prozentangaben jeweils auf das Gesamtgewicht der Zusammensetzung beziehen, und b) ein therapeutisch, kosmetisch oder diagnostisch wirksames Mittel in einer therapeutisch, kosmetisch oder diagnostisch wirksamen Menge.
PCT/EP2010/001742 2009-03-19 2010-03-19 Zubereitung zur äusserlichen anwendung WO2010105842A2 (de)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP10712702A EP2408429A2 (de) 2009-03-19 2010-03-19 Zubereitung zur äusserlichen anwendung
KR1020147014460A KR20150000463A (ko) 2009-03-19 2010-03-19 외용 제제
CN2010800128128A CN102387787A (zh) 2009-03-19 2010-03-19 外用制剂
JP2012500151A JP2012520837A (ja) 2009-03-19 2010-03-19 外用製剤
US13/257,100 US20120064011A1 (en) 2009-03-19 2010-03-19 Preparation for external application

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102009013469.7 2009-03-19
DE102009013469.7A DE102009013469B4 (de) 2009-03-19 2009-03-19 Zubereitung zur äußerlichen Anwendung

Publications (3)

Publication Number Publication Date
WO2010105842A2 WO2010105842A2 (de) 2010-09-23
WO2010105842A3 true WO2010105842A3 (de) 2011-05-26
WO2010105842A9 WO2010105842A9 (de) 2011-12-01

Family

ID=42536329

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2010/001742 WO2010105842A2 (de) 2009-03-19 2010-03-19 Zubereitung zur äusserlichen anwendung

Country Status (7)

Country Link
US (1) US20120064011A1 (de)
EP (1) EP2408429A2 (de)
JP (1) JP2012520837A (de)
KR (2) KR20150000463A (de)
CN (1) CN102387787A (de)
DE (1) DE102009013469B4 (de)
WO (1) WO2010105842A2 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110110841A (ko) 2009-01-28 2011-10-07 어드밴스드 테크놀러지 머티리얼즈, 인코포레이티드 리소그래픽 도구 현장 세척 제형
US20120214874A1 (en) * 2009-08-26 2012-08-23 Nuvo Research Inc. Pharmaceutical formulations and methods of use
DE102011000322A1 (de) 2011-01-25 2012-07-26 saperatec GmbH Trennmedium, Verfahren und Anlage zum Trennen von Mehrschichtsystemen
US11224618B2 (en) 2012-04-16 2022-01-18 Zemtsov Enterprises, Llc Formulations and methods for treatment of acne and inflammatory skin conditions
DE102012212281B3 (de) 2012-07-13 2013-10-31 Schülke & Mayr GmbH Mischung von natürlichen bzw. naturidentischen Alkoholen mit verbesserter Wirksamkeit
SG11201602790TA (en) * 2013-10-11 2016-05-30 Bubbles & Beyond Gmbh Photoresist stripping using intelligent liquids
FR3015872B1 (fr) 2013-12-27 2017-03-24 Oreal Dispositif de maquillage comportant une pluralite d'encres cosmetiques
FR3015888B1 (fr) 2013-12-27 2017-03-31 Oreal Dispositif de maquillage par transfert des matieres keratiniques
FR3015887B1 (fr) 2013-12-27 2017-03-24 Oreal Dispositif et procede pour le maquillage par transfert des matieres keratiniques
FR3015927A1 (fr) 2013-12-27 2015-07-03 Oreal Procede de maquillage par transfert et dispositif associe.
FR3015870B1 (fr) * 2013-12-27 2016-02-05 Oreal Dispositif pour le maquillage par transfert des matieres keratiniques.
FR3015889B1 (fr) 2013-12-27 2016-02-05 Oreal Dispositif pour le maquillage par transfert des matieres keratiniques
FR3015890B1 (fr) 2013-12-27 2016-02-05 Oreal Dispositif pour le maquillage par transfert des matieres keratiniques
RU2763540C2 (ru) 2017-06-29 2021-12-30 Сосьете Де Продюи Нестле С.А. Способ получения бульонной таблетки или бульонного кубика
CA3087822C (en) * 2018-01-18 2022-08-02 Zoetis Broomhill Ip Limited Internal teat sealants and their use in the prevention of bovine mastitis in the dry cow
WO2019145353A1 (en) 2018-01-24 2019-08-01 Societe Des Produits Nestle S.A. Process for preparing a bouillon tablet
US20210030042A1 (en) 2018-04-06 2021-02-04 Societe Des Produits Nestle S.A. Process for preparing a bouillon tablet
WO2019192959A1 (en) 2018-04-06 2019-10-10 Societe Des Produits Nestle S.A. Process for preparing a bouillon tablet
MX2020008875A (es) 2018-04-06 2020-09-25 Nestle Sa Proceso para preparar una tableta de caldo.
AU2019249724A1 (en) 2018-04-06 2020-08-20 Societe Des Produits Nestle S.A. Process for preparing a bouillon tablet
MX2020009447A (es) 2018-05-09 2020-10-15 Nestle Sa Proceso para la produccion de una composicion alimenticia con capacidad de flujo mejorada.
CA3128434A1 (en) 2019-02-01 2020-08-06 Societe Des Produits Nestle S.A. Bouillon tablet
AU2020335131A1 (en) 2019-08-23 2021-12-23 Société des Produits Nestlé S.A. Process for preparing a bouillon tablet
CN114096160A (zh) 2019-08-26 2022-02-25 雀巢产品有限公司 包含水合质构化植物蛋白的仿肉产品
CN114786498A (zh) 2020-01-24 2022-07-22 雀巢产品有限公司 用于包装面条产品的部件套件
WO2021160421A1 (en) 2020-02-11 2021-08-19 Société des Produits Nestlé S.A. A process for producing of a bouillon tablet
IL293973A (en) 2020-02-11 2022-08-01 Nestle Sa Boyon tablet
WO2022100750A1 (zh) * 2020-11-16 2022-05-19 北京厚燊维康科技有限责任公司 可用于光动力治疗或诊断的制剂
WO2022229301A1 (en) 2021-04-28 2022-11-03 Société des Produits Nestlé S.A. A composition of a dehydrated meat analogue product
WO2022229299A1 (en) 2021-04-28 2022-11-03 Société des Produits Nestlé S.A. A composition of a dehydrated meat analogue product
WO2022253643A1 (en) 2021-06-02 2022-12-08 Société des Produits Nestlé S.A. Plant-based meat alternative product with a meat-like color appearance
WO2023217605A1 (en) 2022-05-11 2023-11-16 Société des Produits Nestlé S.A. A process for preparing a meat analogue product
WO2024046744A1 (en) 2022-08-31 2024-03-07 Société des Produits Nestlé S.A. A process for producing a wet savoury product
JP7376758B1 (ja) 2023-07-12 2023-11-09 株式会社Cel-Ena 肌美容方法
CN117224418B (zh) * 2023-11-13 2024-03-19 杭州湃肽生化科技有限公司 一种抗衰老组合物及其产品应用

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2923628A (en) * 1957-11-04 1960-02-02 Harold L Otto Synthetic milk
WO1999006520A1 (en) * 1997-07-31 1999-02-11 E.I. Du Pont De Nemours And Company Aqueous microemulsions
WO2003063617A1 (en) * 2002-01-31 2003-08-07 Archer-Daniels-Midland Company Isotropic transparent compositions containing fat soluble vitamin
WO2004091521A2 (en) * 2003-04-10 2004-10-28 Neurogesx, Inc. Methods and compositions for administration of trpv1 agonists
WO2005063212A1 (en) * 2003-12-31 2005-07-14 Amorepacific Corporation Cholesteryl hemisuccinate incorporated lipid-based nano-carriers and skin-care compositions for external application containing the same
WO2008096351A1 (en) * 2007-02-08 2008-08-14 Nanoderma Ltd. Pharmaceutical compositions based on a microemulsion
WO2009037349A2 (de) * 2007-09-19 2009-03-26 Bubbles & Beyond Gmbh Formulierungen zur entfernung von farbschichten und diversen schmutzschichten von oberflächen, verfahren zur herstellung des mittels und verfahren zur reinigung

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4764381A (en) 1985-12-06 1988-08-16 Key Pharmaceuticals, Inc. Percutaneous penetration enhancer of oleic acid and 2-ethyl-1, 3-hexanediol
US4917896A (en) 1986-08-15 1990-04-17 Nelson Research & Development Co. Penetration enhancers for transdermal delivery of systemic agents
DE3729299A1 (de) 1987-09-02 1989-03-23 Beiersdorf Ag Transdermales therapeutisches system
US5229130A (en) 1991-12-20 1993-07-20 Cygnus Therapeutics Systems Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems
US6113921A (en) 1993-03-23 2000-09-05 Pharmos Corp. Topical and transdermal delivery system utilizing submicron oil spheres
US5853751A (en) 1993-06-23 1998-12-29 Masiz; John J. Molecular transdermal transport system
DE4406753A1 (de) 1994-03-02 1995-09-07 Basf Lacke & Farben Reinigungsmittel, Verfahren zur Herstellung des Reinigungsmittels sowie seine Verwendung
KR100338327B1 (ko) 2000-05-16 2002-08-07 주식회사 태평양 피부 외용제 내의 활성성분의 피부 흡수를 증진시킬 수있는 조성물
ATE355854T1 (de) 2000-08-03 2007-03-15 Antares Pharma Ipl Ag Neue zusammensetzung zur transdermalen und/oder transmukosalen wirkstoffanwendung mit geeignetem therapeutischen spiegel

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2923628A (en) * 1957-11-04 1960-02-02 Harold L Otto Synthetic milk
WO1999006520A1 (en) * 1997-07-31 1999-02-11 E.I. Du Pont De Nemours And Company Aqueous microemulsions
WO2003063617A1 (en) * 2002-01-31 2003-08-07 Archer-Daniels-Midland Company Isotropic transparent compositions containing fat soluble vitamin
WO2004091521A2 (en) * 2003-04-10 2004-10-28 Neurogesx, Inc. Methods and compositions for administration of trpv1 agonists
WO2005063212A1 (en) * 2003-12-31 2005-07-14 Amorepacific Corporation Cholesteryl hemisuccinate incorporated lipid-based nano-carriers and skin-care compositions for external application containing the same
WO2008096351A1 (en) * 2007-02-08 2008-08-14 Nanoderma Ltd. Pharmaceutical compositions based on a microemulsion
WO2009037349A2 (de) * 2007-09-19 2009-03-26 Bubbles & Beyond Gmbh Formulierungen zur entfernung von farbschichten und diversen schmutzschichten von oberflächen, verfahren zur herstellung des mittels und verfahren zur reinigung

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
MERCK: "The Merck Manual", 1 January 2001, MERCK, Whitehouse Station, ISBN: 0911910131, article "Lecithin", pages: 5443, XP002621698 *
See also references of EP2408429A2 *
vol. 5, 1 January 1995, J FALBE, Stuttgart, New York, ISBN: 3131027592, article "Polyethylenglykole", pages: 3532, XP002621699 *

Also Published As

Publication number Publication date
EP2408429A2 (de) 2012-01-25
WO2010105842A9 (de) 2011-12-01
JP2012520837A (ja) 2012-09-10
DE102009013469A1 (de) 2010-12-09
US20120064011A1 (en) 2012-03-15
CN102387787A (zh) 2012-03-21
DE102009013469B4 (de) 2014-04-17
KR20150000463A (ko) 2015-01-02
KR20110135973A (ko) 2011-12-20
WO2010105842A2 (de) 2010-09-23

Similar Documents

Publication Publication Date Title
WO2010105842A9 (de) Zubereitung zur äusserlichen anwendung
WO2019030458A3 (fr) Emulsion moussante a haute teneur en huile et ses utilisations, notamment pour l'hygiene corporelle
WO2011065771A3 (en) Cosmetic composition stabilized higher oily part
JP2010527332A (ja) 界面活性剤不含泡沫処方物
CN105188660A (zh) 化妆品组合物
WO2007117352A3 (en) Topical therapeutic delivery system
PH12015501046B1 (en) Bpo wash emulsion composition
WO2013098066A3 (de) Wässrige haar- und hautreinigungszusammensetzungen, enthaltend biotenside
WO2007112996A3 (en) Use of compounds and combinations of compounds for improving the physical appearance
WO2012085523A3 (en) Skin sanitizer compositions comprising alcohol based emulsion
SI2437762T1 (en) Artificial tears and therapeutic use
WO2012103038A3 (en) Nanoparticle compositions, formulations thereof, and uses therefor
CN101198375A (zh) 作为减轻发痒用化妆品和药用组合物的包含邻氨基苯甲酸酰胺和清凉剂的混合物
WO2013130948A3 (en) Sunscreen composition comprising uv composite
EP2996668A2 (de) Kosmetische zusammensetzung mit einen sebum-steuerungsmittel, einem hautschuppenablösungsmittel und/oder einem kollagenverstärkenden mittel sowie mit porösen vernetzten polymethylmethacrylat-perlenpartikeln
IN2012DN03123A (de)
AU2016222343A1 (en) Compositions and methods for treating blackheads
WO2010091827A3 (de) Kosmetische zubereitung zur hautpflege
WO2014097258A3 (en) Aqueous cosmetic composition comprising alkylcellulose
EP1793792A4 (de) Zusammensetzung aus dem extrakt von actinidia arguta zur prävention und behandlung von alopezie und seborrhöischen hauterkrankungen
JP2015512428A5 (de)
JP6639816B2 (ja) 化粧料
WO2010107482A3 (en) Germicidal composition
CN103550097A (zh) 一种温和卸妆油
JP6554394B2 (ja) 化粧料

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080012812.8

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10712702

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2012500151

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 4153/KOLNP/2011

Country of ref document: IN

Ref document number: 2010712702

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 20117024532

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 13257100

Country of ref document: US